Instituto Universitario de Farmacia Industrial
Zentrum/Institut
University of Portsmouth
Portsmouth, Reino UnidoPublikationen in Zusammenarbeit mit Forschern von University of Portsmouth (25)
2022
-
Microfluidic Manufacture of Lipid-Based Nanomedicines
Pharmaceutics, Vol. 14, Núm. 9
-
Solid Nanomedicines of Nifurtimox and Benznidazole for the Oral Treatment of Chagas Disease
Pharmaceutics, Vol. 14, Núm. 9
2021
-
3D printed spherical mini-tablets: Geometry versus composition effects in controlling dissolution from personalised solid dosage forms
International Journal of Pharmaceutics, Vol. 597
-
Engineering 3d printed microfluidic chips for the fabrication of nanomedicines
Pharmaceutics, Vol. 13, Núm. 12
-
Mimicking bone microenvironment: 2D and 3D in vitro models of human osteoblasts
Pharmacological Research, Vol. 169
-
Nanoemulsified Butenafine for Enhanced Performance against Experimental Cutaneous Leishmaniasis
Journal of Immunology Research, Vol. 2021
-
Understanding direct powder extrusion for fabrication of 3d printed personalised medicines: A case study for nifedipine minitablets
Pharmaceutics, Vol. 13, Núm. 10
2020
-
Personalised 3d printed medicines: Optimising material properties for successful passive diffusion loading of filaments for fused deposition modelling of solid dosage forms
Pharmaceutics, Vol. 12, Núm. 4
-
Topical buparvaquone nano-enabled hydrogels for cutaneous leishmaniasis
International Journal of Pharmaceutics, Vol. 588
-
Transferosomes as nanocarriers for drugs across the skin: Quality by design from lab to industrial scale
International Journal of Pharmaceutics, Vol. 573
-
Ultradeformable Lipid Vesicles Localize Amphotericin B in the Dermis for the Treatment of Infectious Skin Diseases
ACS Infectious Diseases, Vol. 6, Núm. 10, pp. 2647-2660
2019
-
Designing fast-dissolving orodispersible films of amphotericin b for oropharyngeal candidiasis
Pharmaceutics, Vol. 11, Núm. 8
-
Market demands in 3D printing pharmaceuticals products
3D Printing Technology in Nanomedicine (Elsevier), pp. 165-183
-
Repurposing butenafine as an oral nanomedicine for visceral leishmaniasis
Pharmaceutics, Vol. 11, Núm. 7
-
Technology-enhanced learning in higher education: How to enhance student engagement through blended learning
European Journal of Education, Vol. 54, Núm. 2, pp. 273-286
-
Tuning the transdermal delivery of hydroquinone upon formulation with novel permeation enhancers
Pharmaceutics, Vol. 11, Núm. 4
2018
-
Applying loop-mediated isothermal amplification (LAMP) in the diagnosis of malaria, leishmaniasis and trypanosomiasis as point-of-care tests (POCTs)
Current Topics in Medicinal Chemistry, Vol. 18, Núm. 16, pp. 1358-1374
-
Orally Bioavailable and Effective Buparvaquone Lipid-Based Nanomedicines for Visceral Leishmaniasis
Molecular Pharmaceutics, Vol. 15, Núm. 7, pp. 2570-2583
2017
-
Engineering oral and parenteral amorphous amphotericin B formulations against experimental Trypanosoma cruzi infections
Molecular Pharmaceutics, Vol. 14, Núm. 4, pp. 1095-1106
-
Engineering synergistically active and bioavailable cost-effective medicines for neglected tropical diseases; the role of excipients
Current Topics in Medicinal Chemistry, Vol. 17, Núm. 25, pp. 2888-2900